org placeholder image

Marie Minassian

Director, Regulatory Affairs at Entasis Therapeutics

  • LinkedIn

Email Email: m****@entasistx.com

phone noPhone Number: (***)-***-****

map
ENTASIS THERAPEUTICS

ENTASIS THERAPEUTICS

  • description Description
    Entasis Therapeutics, a subsidiary of Innoviva, Inc., is developing a portfolio of innovative cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives...

    Read More

  • Employees count Employees 51-200
  • Revenue Revenue 10 Million to 25 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Entasis Therapeutics Org Chart and Mapping

Employees

Khurram Rana

Director, Clinical Scientist

John Mueller

Chief Development Officer

Drew Lewis

Vice President Clinical Development

Richard Schild

Head API, Pharmaceutical Sciences

Marie Minassian

Director, Regulatory Affairs

Maryellen Garrett

Sr. Director, Corporate Controller

Frequently Asked Questions Regarding Marie Minassian

Answer: Marie Minassian works for Entasis Therapeutics as Director, Regulatory Affairs

Answer: Marie Minassian’s role in Entasis Therapeutics is Director, Regulatory Affairs

Answer: Marie Minassian's email address is m***@gmail.com

Answer: Marie Minassian's business email address is m****@entasistx.com

Answer: Marie Minassian’s direct phone number is (***)-***-****

Answer: Marie Minassian works in the industry of: Biotechnology

Answer: Marie Minassian works Entasis Therapeutics located at 35 Gatehouse Dr, Waltham, Massachusetts, 02451, United States

Answer: Entasis Therapeutics's Director, Regulatory Affairs is Marie Minassian

Answer: Marie Minassian contact details:

  • Phone number  :  (***)-***-****
  • Email  :  m****@entasistx.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access